Literature DB >> 25010175

Reversible nyctalopia and retinopathy in a patient with metastatic cancer treated with anti-heat shock protein 90 therapy.

Marion R Munk1, Joshua Fernandes2, Marilyn Mets2, Jyoti D Patel3, Melissa L Johnson3, Lee M Jampol2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25010175     DOI： 10.1001/jamaophthalmol.2014.409

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  1 in total

1.  Phase I/II Study of HSP90 Inhibitor AUY922 and Erlotinib for EGFR-Mutant Lung Cancer With Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.

Authors:  Melissa L Johnson; Helena A Yu; Eric M Hart; Bing Bing Weitner; Alfred W Rademaker; Jyoti D Patel; Mark G Kris; Gregory J Riely
Journal:  J Clin Oncol       Date:  2015-04-13       Impact factor: 44.544
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.